Fresenius Kabi

Fresenius Kabi Ivenix Pump Sees Second Recall in 2024
Medical Devices and Diagnostics Industry
Wed, 09/18/24 - 11:13 pm
Medtech
Fresenius Kabi
device recalls
Ivenix Infusion Pump LVP
Fresenius Kabi USA Infusion Pump Software Recall Declared Class I
Medical Devices and Diagnostics Industry
Fri, 04/19/24 - 11:20 am
Medtech
Fresenius Kabi
Ivenix Infusion Pump LVP
device recalls
Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval
BioSpace
Sun, 03/10/24 - 08:25 pm
Fresenius Kabi
FDA
biosimilars
Actemra
Tyenne
Genentech
J&J's Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
Fierce Pharma
Mon, 08/7/23 - 10:52 am
JNJ
Stelara
patents
legal
Formycon
Fresenius Kabi
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
AbbVie
Humira
biosimilars
Boehringer Ingelheim
Organon
Samsung Bioepsis
Sandoz
Fresenius Kabi
Celltrion
Coherus Biosciences
Biocon
Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US
Pharmaceutical Business Review
Fri, 02/17/23 - 09:44 am
Fresenius Kabi
Stimufend
pegfilgrastim
biosimilars
Neulasta
Amgen
cancer
Amgen's Neulasta gains another biosimilar competitor as sales slip
Endpoints
Thu, 09/8/22 - 04:35 pm
Amgen
Neulasta
Fresenius Kabi
biosimilars
FDA
Stimufend
Fresenius Kabi pays $50 million to settle criminal charges
RAPS.org
Wed, 02/10/21 - 10:22 pm
Fresenius Kabi
India
drug manufacturing
FDA
criminal charges
Fresenius Kabi recalls hospital sedative on accidental mix with lidocaine—again
Fierce Pharma
Fri, 11/20/20 - 11:18 am
Fresenius Kabi
product recalls
anesthetics
Fresenius Kabi recalls anti-inflammation drug Ketorolac after finding particles in vials
Fierce Pharma
Thu, 05/7/20 - 12:11 am
Fresenius Kabi
Ketorolac
FDA
product recalls
Fresenius moves forward with two U.S. expansions after killing Akorn deal
Fierce Pharma
Wed, 04/10/19 - 10:58 am
Fresenius Kabi
Akorn
drug manufacturing
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Mon, 10/22/18 - 05:17 pm
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
AbbVie wards off another Humira biosim challenger with Fresenius Kabi settlement
Fierce Pharma
Thu, 10/18/18 - 11:29 pm
Humira
AbbVie
Fresenius Kabi
Europe